ATE486540T1 - Verwendung von alginat-matrizen zur kontrolle des zellwachstums - Google Patents

Verwendung von alginat-matrizen zur kontrolle des zellwachstums

Info

Publication number
ATE486540T1
ATE486540T1 AT04815696T AT04815696T ATE486540T1 AT E486540 T1 ATE486540 T1 AT E486540T1 AT 04815696 T AT04815696 T AT 04815696T AT 04815696 T AT04815696 T AT 04815696T AT E486540 T1 ATE486540 T1 AT E486540T1
Authority
AT
Austria
Prior art keywords
disclosed
alginate
methods
cell growth
devices
Prior art date
Application number
AT04815696T
Other languages
English (en)
Inventor
Jan Melvik
Michael Dornish
Original Assignee
Fmc Biopolymer As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Biopolymer As filed Critical Fmc Biopolymer As
Application granted granted Critical
Publication of ATE486540T1 publication Critical patent/ATE486540T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT04815696T 2003-12-23 2004-12-23 Verwendung von alginat-matrizen zur kontrolle des zellwachstums ATE486540T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53191703P 2003-12-23 2003-12-23
PCT/US2004/043681 WO2005063147A1 (en) 2003-12-23 2004-12-23 Use of alginate matrices to control cell growth

Publications (1)

Publication Number Publication Date
ATE486540T1 true ATE486540T1 (de) 2010-11-15

Family

ID=34738717

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04815696T ATE486540T1 (de) 2003-12-23 2004-12-23 Verwendung von alginat-matrizen zur kontrolle des zellwachstums

Country Status (13)

Country Link
US (2) US7790193B2 (de)
EP (2) EP2228035A1 (de)
JP (2) JP4869945B2 (de)
CN (1) CN1897890B (de)
AT (1) ATE486540T1 (de)
AU (1) AU2004308511B2 (de)
BR (1) BRPI0417776A (de)
CA (1) CA2548305C (de)
DE (1) DE602004029928D1 (de)
IL (2) IL176268A0 (de)
MX (1) MXPA06006930A (de)
NZ (1) NZ547829A (de)
WO (1) WO2005063147A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005001080A2 (en) * 2003-06-27 2005-01-06 Ethicon, Incorporated Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
CA2548305C (en) 2003-12-23 2014-07-15 Fmc Biopolymer As Use of alginate matrices to control cell growth
EP1799232B1 (de) 2004-10-12 2015-10-07 FMC Biopolymer AS Selbstgelierende alginatsysteme und verwendungsmöglichkeiten dafür
CA2643083A1 (en) * 2006-03-01 2007-09-13 Fmc Biopolymer As Biodegradable foam
WO2007146319A2 (en) * 2006-06-13 2007-12-21 Symphony Medical, Inc. Methods and apparatus for using polymer-based beads and hydrogels for cardiac applications
ES2386123T3 (es) * 2006-06-16 2012-08-09 Fmc Biopolymer As Dispositivo celular con una matriz de colágeno revestida de alginato, proceso para su formación y utilizaciones
ATE548059T1 (de) * 2006-10-17 2012-03-15 Univ Tokai Educational System Bioartifizieller nierentubulus
DE102006054789B4 (de) * 2006-11-21 2008-09-25 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren und Vorrichtung zur Behandlung biologischer Zellen auf einem Substrat
EP2152860A4 (de) * 2007-06-13 2011-12-07 Fmc Corp Peptidgebundene zellmatrixmaterialien für stammzellen und ihre verwendung
CN103463638A (zh) * 2007-08-28 2013-12-25 Fmc有限公司 延迟的自胶凝藻酸盐体系及其应用
US9056150B2 (en) * 2007-12-04 2015-06-16 Warsaw Orthopedic, Inc. Compositions for treating bone defects
PL2231209T3 (pl) * 2007-12-20 2019-08-30 Ethicon, Incorporated Enkapsulowana tkanka nerkowa
US9540630B2 (en) 2008-09-17 2017-01-10 Beta O2 Technologies Ltd. Optimization of alginate encapsulation of islets for transplantation
WO2011154941A2 (en) 2010-06-07 2011-12-15 Beta-O2 Technologies Ltd. Multiple-layer immune barrier for donor cells
EP2688397B1 (de) * 2011-03-21 2016-07-20 University of Reading Transport von zellen in alginat-hydrogelen
DK3354665T5 (da) 2011-06-02 2022-09-19 Massachusetts Inst Technology Modificerede alginater til celleindkapsling og celleterapi
CN104922682A (zh) * 2014-03-20 2015-09-23 中国科学院大连化学物理研究所 一种胰蛋白酶抑制剂及其应用
KR102719485B1 (ko) 2014-08-01 2024-10-21 메사추세츠 인스티튜트 오브 테크놀로지 항-섬유 물질 및 응용을 위한 변형된 알기네이트
NZ742800A (en) 2015-11-01 2019-03-29 Massachusetts Inst Technology Modified alginates for anti-fibrotic materials and applications
AU2016344041B2 (en) 2015-11-01 2019-11-07 Massachusetts Institute Of Technology Materials with improved properties
EP3380655A4 (de) * 2015-11-25 2019-04-10 NUtech Ventures System zur zellherstellung in grossem umfang
CN109219440A (zh) * 2016-04-04 2019-01-15 贝塔O2技术有限公司 用于植入具有抗炎和血管化能力的细胞的可植入设备及其制造方法
CA3027200A1 (en) 2016-06-13 2017-12-21 Massachusetts Institute Of Technology Biocompatible zwitterionic polymer coatings and hydrogels for reducing foreign body response and fibrosis
US11318231B2 (en) 2017-11-06 2022-05-03 Massachusetts Institute Of Technology Anti-inflammatory coatings to improve biocompatibility of neurological implants
GB201801014D0 (en) * 2018-01-22 2018-03-07 Univ Newcastle Storage and/or transport for multicellular aggregates
US12558452B2 (en) 2019-03-20 2026-02-24 Public University Corporation Yokohama City University Coating-securing agent

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459054A (en) * 1989-12-05 1995-10-17 Neocrin Company Cells encapsulated in alginate containing a high content of a- l- guluronic acid
US5318780A (en) 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5643594A (en) 1992-05-29 1997-07-01 The Regents Of The University Of California Spin encapsulation apparatus and method of use
US5531716A (en) 1993-09-29 1996-07-02 Hercules Incorporated Medical devices subject to triggered disintegration
US5876742A (en) 1994-01-24 1999-03-02 The Regents Of The University Of California Biological tissue transplant coated with stabilized multilayer alginate coating suitable for transplantation and method of preparation thereof
US5900238A (en) 1995-07-27 1999-05-04 Immunex Corporation Vaccine delivery system
JP2001517494A (ja) 1997-09-19 2001-10-09 リプロジェネシス・インコーポレーテッド 組織エンジニアリングのための改良されたヒドロゲル
JP3261456B2 (ja) * 1999-10-29 2002-03-04 独立行政法人産業技術総合研究所 細胞培養担体及び該担体を用いた細胞の培養方法
US6638917B1 (en) 2000-02-25 2003-10-28 Scimed Life Systems, Inc. Reducing adhesion
WO2002024107A2 (en) * 2000-09-20 2002-03-28 Islet Sheet Medical Llc Fabrication of thin sheet bio-artificial organs
JP2003259862A (ja) * 2002-03-12 2003-09-16 Fuji Photo Film Co Ltd 細胞培養担体
CA2548305C (en) 2003-12-23 2014-07-15 Fmc Biopolymer As Use of alginate matrices to control cell growth

Also Published As

Publication number Publication date
CA2548305A1 (en) 2005-07-14
JP4869945B2 (ja) 2012-02-08
EP1696825A4 (de) 2008-05-14
MXPA06006930A (es) 2007-01-26
NZ547829A (en) 2009-04-30
AU2004308511A1 (en) 2005-07-14
DE602004029928D1 (de) 2010-12-16
US7790193B2 (en) 2010-09-07
US20100304484A1 (en) 2010-12-02
US8541017B2 (en) 2013-09-24
US20050169895A1 (en) 2005-08-04
JP2007517051A (ja) 2007-06-28
EP1696825A1 (de) 2006-09-06
EP1696825B1 (de) 2010-11-03
AU2004308511B2 (en) 2010-09-16
CA2548305C (en) 2014-07-15
WO2005063147A1 (en) 2005-07-14
BRPI0417776A (pt) 2007-03-20
CN1897890A (zh) 2007-01-17
CN1897890B (zh) 2012-01-25
EP2228035A1 (de) 2010-09-15
JP2011032290A (ja) 2011-02-17
JP5410401B2 (ja) 2014-02-05
IL205151A (en) 2012-02-29
IL176268A0 (en) 2006-10-05

Similar Documents

Publication Publication Date Title
ATE486540T1 (de) Verwendung von alginat-matrizen zur kontrolle des zellwachstums
Barois et al. Ecology of earthworm species with large environmental tolerance and/or extended distributions
DE69630891T2 (de) Unterstützungsvorrichtung für pflanzenkultur und anwendungsmethode zum pflanzenwuchs
US6995013B2 (en) Cell-scaffold composition containing five layers
ATE250666T1 (de) Verfahren zur herstellung von knorpelgewebe und von implantaten
ATE216255T1 (de) Lokale abgabe von faktoren die des überlebens von transplantierten zellen verhögen
ATE356838T1 (de) Biosynthetische matrix und deren verwendung
DE60135019D1 (de) Elektroverarbeitetes kollagen
WO2000017322A3 (en) Electroactive materials for stimulation of biological activity of cells
DE69028524D1 (de) In vivo-neomorphogenese von knorpel aus zellkulturen
WO2004113513A3 (en) Methods and compositions for modulating stem cell growth and differentiation
ATE297169T1 (de) Auffindbare künstliche bioimplantate
MXPA03001914A (es) Matrices basadas en fibrina electroprocesada y tejidos.
BR0210599A (pt) Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
DE3751843D1 (de) Herstellung von körperorganen durch kontroliertes zellwachstum auf künstlicher matrix
DK0549774T3 (da) Anvendelse af porøst calciumcarbonat som bærermateriale for in vitro cellekulturer
WO2004030706A3 (en) Bioactive implants
WO2003099230A3 (en) Electroprocessed collagen and tissue engineering
DE69921297D1 (de) Pflanzenwachstumsmedium mit hydrophilem Membrane und Verwendung der Membrane zur Kontrolle der Feuchtigkeit
CA2073453A1 (en) Methods of enhancing wound healing and tissue repair
KR101480206B1 (ko) 3차원 세포 배양방법
WO2007005828A3 (en) Cell growth and cell transplant devices for gene therapy
CN208151069U (zh) 一种净化水质的复合景观生态浮床
WO2001025403A3 (en) Bio-artificial substrate for the production of animal and, in particular, human tissues and organs
ATE268182T1 (de) Transplantations/implantatsvorrichtung und ihre herstellungsmethode

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties